MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$31,820K
EPS
-$0.48
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
29,145 21,314* 28,988 24,087
General and administrative
7,289 7,223* 5,117 4,342
Total operating expenses
36,434 28,536 34,105 28,429
Loss from operations
-36,434 -28,536* -34,105 -28,429
Other expense, net
--4 2
Interest income
4,606 5,097* 3,832 3,857
Interest expense
---0
Other income (expense), net
8 -3* --
Total other income, net
4,614 5,094* 3,828 3,855
Net loss
-31,820 -23,443 -30,277 -24,574
Net change in unrealized gains (losses) on marketable securities
--212 -21
Comprehensive loss
---30,065 -24,595
Basic EPS
-0.48 -0.463 -0.55 -0.46
Diluted EPS
-0.48 -0.463 -0.55 -0.46
Basic Average Shares
55,172,410 50,679,416 44,067,059 42,095,951
Diluted Average Shares
55,172,410 50,679,416 44,067,059 42,095,951
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$4,606K Other income(expense), net$8K Net loss-$31,820K Total other income,net$4,614K Loss from operations-$36,434K Total operatingexpenses$36,434K Research and development$29,145K General andadministrative$7,289K

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA)